» Articles » PMID: 24843431

Fasting Tests of Insulin Secretion and Sensitivity Predict Future Prediabetes in Japanese with Normal Glucose Tolerance

Overview
Specialty Endocrinology
Date 2014 May 21
PMID 24843431
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Aims/Introduction:  Reduced insulin sensitivity and secretion are important in the pathogenesis of type 2 diabetes. Their relationships to prediabetes, impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have been previously studied with the oral glucose tolerance test (OGTT). We investigated whether or not baseline measures of insulin secretion and sensitivity obtained from fasting blood specimens were related to the development of prediabetes and how these measures compared with those based on the OGTT.

Materials And Methods:   In 152 Japanese subjects with normal glucose tolerance, we measured baseline plasma glucose and insulin after an overnight fast and during a 75 g OGTT, insulin resistance index (homeostasis model assessment [HOMA-IR]), and insulin secretion (insulinogenic index [30 min insulin - fasting insulin] ÷ [30 min glucose - fasting glucose] or HOMA-β).

Results:   At a 5-6 year (mean 5.7 years) follow-up examination, we confirmed 36 cases of prediabetes. After adjusting for age, sex, family history of diabetes, body mass index, and 2-h plasma glucose, the odds ratio comparing the lowest tertile (≤0.82) of insulinogenic index with the highest tertile (≥1.43) was 6.98 (95% confidence interval, 1.96-24.85) and was 10.72 (2.08-55.3) comparing the lowest tertile (≤76.3) of HOMA-β with the highest tertile (≥122.1), whereas the respective odds ratios of HOMA-IR were 3.74 (1.03-13.57) and 10.89 (1.93-61.41) comparing the highest tertile (≥1.95) with the lowest tertile (≤1.25).

Conclusions:   Lower insulin secretion and sensitivity are independent risk factors for prediabetes. Clinically practical identification of those at risk for prediabetes is obtainable from HOMA-β and HOMA-IR, both of which are measured in fasting state. (J Diabetes Invest, doi: 10.1111.j.2040-1124.2010.00041.x, 2010).

Citing Articles

Antihyperglycemic activity of a novel polyherbal formula (HF344), a mixture of fifteen herb extracts, for the management of type 2 diabetes: Evidence from and studies.

Kitphati W, Sato V, Peungvicha P, Saengklub N, Chewchinda S, Kongkiatpaiboon S Heliyon. 2024; 10(19):e38703.

PMID: 39421370 PMC: 11483321. DOI: 10.1016/j.heliyon.2024.e38703.


The effect of spirulina sauce on glycemic index, lipid profile, and oxidative stress in type 2 diabetic patients: A randomized double-blind clinical trial.

Rezaiyan M, Sasani N, Kazemi A, Mohsenpour M, Babajafari S, Mazloomi S Food Sci Nutr. 2023; 11(9):5199-5208.

PMID: 37701187 PMC: 10494644. DOI: 10.1002/fsn3.3479.


Antihyperglycemic effects of leaf extract and .

Goli A, Sato V, Sato H, Chewchinda S, Leanpolchareanchai J, Nontakham J Pharm Biol. 2023; 61(1):189-200.

PMID: 36625086 PMC: 9848344. DOI: 10.1080/13880209.2022.2160771.


Is there any difference in insulin resistance status between cases of benign and malignant ovarian neoplasms? A study on surrogate markers of insulin resistance in Indonesian non-diabetic women.

Winarto H, Habiburrahman M, Febriana I, Kusuma F, Nuryanto K, Anggraeni T Oncol Lett. 2022; 25(1):23.

PMID: 36478903 PMC: 9713771. DOI: 10.3892/ol.2022.13609.


Investigation of the Chemical Composition, Antihyperglycemic and Antilipidemic Effects of and Its Derived Constituent, Umbelliferone on High-Fat Diet and Streptozotocin-Induced Diabetic Rats.

Al Mouslem A, Khalil H, Emeka P, Alotaibi G Molecules. 2022; 27(20).

PMID: 36296534 PMC: 9611308. DOI: 10.3390/molecules27206941.


References
1.
Wild S, Roglic G, Green A, Sicree R, King H . Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004; 27(5):1047-53. DOI: 10.2337/diacare.27.5.1047. View

2.
Faerch K, Vaag A, Holst J, Hansen T, Jorgensen T, Borch-Johnsen K . Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care. 2008; 32(3):439-44. PMC: 2646025. DOI: 10.2337/dc08-1195. View

3.
Shaw J, Hodge A, de Courten M, Chitson P, Zimmet P . Isolated post-challenge hyperglycaemia confirmed as a risk factor for mortality. Diabetologia. 1999; 42(9):1050-4. DOI: 10.1007/s001250051269. View

4.
. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20(7):1183-97. DOI: 10.2337/diacare.20.7.1183. View

5.
Alberti K . Screening and diagnosis of prediabetes: where are we headed?. Diabetes Obes Metab. 2007; 9 Suppl 1:12-6. DOI: 10.1111/j.1463-1326.2007.00764.x. View